Financial Daily from THE HINDU group of publications
Saturday, Mar 06, 2004
Financial Daily from THE HINDU group of publications Saturday, Mar 06, 2004 |
||
|
|
||
|
Corporate
-
Announcements Marketing - New Products & Services Industry & Economy - Health Ranbaxy launches first prescription drug in the UK Our Bureau
New Delhi , March 5 RANBAXY Laboratories Ltd has launched its first branded prescription medicine, Visclair Tablets, in the UK. The brand will be promoted to health professionals by the Ranbaxy respiratory sales team.Visclair is a mucolytic drug that aids the expectoration of viscous mucus, a problem associated with respiratory diseases such as chronic obstructive pulmonary disease (COPD). Clearing viscous mucus from the patient's lungs can reduce the chronic cough, respiratory infections and exacerbations that COPD patients suffer from. In a company statement, Mr Malvinder Mohan Singh, President-Pharmaceuticals, Ranbaxy, said, ``The launch of Visclair is a significant step towards our committed foray into the branded prescription segment in the UK market." The company claimed that COPD is the fifth commonest cause of death in England and Wales, accounting for approximately 30,000 deaths each year. Predominantly caused by smoking, there are an estimated 9-lakh people in the UK with diagnosed COPD.
More Stories on : Announcements | New Products & Services | Health | Pharmaceuticals
Article E-Mail :: Comment :: Syndication :: Printer Friendly Page
|
Stories in this Section |
|
The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription Group Sites: The Hindu | Business Line | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |
Copyright © 2004, The
Hindu Business Line. Republication or redissemination of the contents of
this screen are expressly prohibited without the written consent of
The Hindu Business Line
|